Fitbit uses photoplethysmography technology to track blood flow from participants’ wrists and determine their heart rhythm. Participants with irregular heart rhythm will receive a notification and be offered a virtual appointment with a physician at no cost. They also may receive a free electrocardiogram patch in the mail.
The detection of heart rhythm irregularities is ideal when the body is at rest. Fitbit devices’ long battery life allows users to wear the device for days, which ensures that heart rhythms are accessed when users are asleep.
The study comes after Apple launched a similar AFib detection study last February that produced lackluster results.
Read the full press release here.
More articles on data analytics:
Physician viewpoint: US needs widespread data sharing to ensure ventilators, PPE are used
51 Florida hospitals form COVID-19 data exchange: 4 things to know
Cleveland Clinic applies EHR data, analytics to COVID-19 research initiative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
